Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study.

Physiological research - 23 Nov 2016

Dravecká I, Figurová J, Javorský M, Petríková J, Vaľková M, Lazúrová I

Abstract excerpt

Aim of this study was to evaluate the effect of vitamin D supplementation in obese, insulin resistant and vitamin D deficient PCOS women on biochemical and clinical hyperandrogenism and menstrual irregularity in comparison to effect of metformin or combined metformin plus vitamin D therapy. Thirty nine PCOS women were randomized into three groups and treated with alfacalcidiol (Group 1), combined alfacalcidiol...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hyperandrogenism
Share to Hypoglycemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin Resistance

Share to Menstrual Cycle

Share to Metformin

Share to Pilot Projects

Share to Polycystic Ovary Syndrome

Share to Pregnancy Rate

Source

Identifiers

PMID: 27429113
DOI: 10.33549/physiolres.933266

Genes

TST

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study.PMID 27429113Read ↗

Exploring the Therapeutic Potential of Natural Products on Polycystic Ovarian Syndrome (PCOS): A Mini Review of Lipid Profile, Blood Glucose, and Ovarian Histological ImprovementsSemantic proximity Read ↗

[Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].Semantic proximity Read ↗

Metformin Effects on Follistatin and Oxyntomodulin Levels and Its Relationship With Polycystic Ovaries Syndrome and Associated Comorbidities: Secondary Analysis of Randomized Double-blind Clinical Study.Semantic proximity Read ↗

Metformin treatment in different phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

Association between Vitamin D and pregnancy in women with polycystic ovary syndrome: a case-control study from Beijing, ChinaSemantic proximity Read ↗

Metformin's Impact on Follistatin and Oxyntomodulin in PCOS, and Comorbidities: Secondary Analysis of a Double-Blind RCTSemantic proximity Read ↗

The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism.Semantic proximity Read ↗

Impact of vitamin D deficiency on phenotypes and IVF outcomes in PCOS: a prospective study.Semantic proximity Read ↗

The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndromeSemantic proximity Read ↗

Modulation of steroidogenesis by Actaea racemosa and vitamin C combination, in letrozole induced polycystic ovarian syndrome rat model: Promising activity without the risk of hepatic adverse effectSemantic proximity Read ↗

The Role of Vitamin D in Reproductive Health—A Trojan Horse or the Golden Fleece?Semantic proximity Read ↗

Metformin prevents oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome via activation of Nrf2-HO-1 pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.